412375000: Tetanus vaccine (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
tetanusvaccine	Is a	Drug allergen	false	Inferred relationship	Some
tetanusvaccine	Is a	vaccine	false	Inferred relationship	Some
tetanusvaccine	Is a	bakterievaccine	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
tetanusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	1
difteri- + tetanusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	2
Haemophilus influenzae type B- + tetanusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	2
Administration of vaccine product containing only acellular Bordetella pertussis five component and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
humant tetanustoxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
Administration of second dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	3
Administration of second dose of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Equine influenza vaccine - tetanus toxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
Administration of booster dose of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Haemophilus influenzae type B-polysaccharidvaccine 10 µg + tetanustoxoid 24 µg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
Administration of final dose of vaccine product containing only Clostridium tetani antigen (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of diphtheria and tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
difteri- + tetanus- + Haemophilus influenzae type b-vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	3
adsorberet tetanusvaccine injektionsvæske, opløsning i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
adsorberet tetanus- og difteritoxoid til voksne	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
adsorberet tetanustoxoid 10 enheder til intramuskulær anvendelse, injektionsvæske, suspension, sprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
Administration of first dose of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
adsorberet difteri- + tetanus- + kighostevaccine injektionsvæske, hætteglas a 7,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
Clostridium perfringens type D-tetanustoxoid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
højdosisdifteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
adsorberet difteri- + tetanus- + kighostevaccine injektionsvæske, hætteglas a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
Administration of first booster of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
vaccination mod difteri, kighoste, stivkrampe og polio, ikke nærmere specificeret	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Di-Te-vaccination i førskolealderen	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
lavdosis difteri-/tetanus-/kighoste-/inaktiveret poliovaccine, i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
difteri- + kighoste- + tetanusvaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	3
vaccination mod difteri, kighoste og stivkrampe, ikke nærmere specificeret	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of second dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
dobbeltvaccination mod difteri og stivkrampe samt polio	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of poliomyelitis and tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Administration of first dose of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of third dose of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
1. vaccination mod difteri, kighoste og stivkrampe	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
2. vaccination mod difteri, kighoste og stivkrampe	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
vaccination mod difteri, kighoste, stivkrampe og polio	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
1. vaccination mod difteri, kighoste, stivkrampe og polio	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
3. vaccination mod difteri, kighoste, stivkrampe og polio	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
1. dobbeltvaccination mod difteri og stivkrampe	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
2. dobbeltvaccination mod difteri og stivkrampe	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
booster-dobbeltvaccination mod difteri og stivkrampe	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
dobbeltvaccination med lav dosis mod stivkrampe og difteri	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
dobbeltvaccination mod difteri og stivkrampe, ikke nærmere specificeret	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
1. dobbeltvaccination mod difteri og stivkrampe samt polio	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
3. dobbeltvaccination mod difteri og stivkrampe samt polio	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
dobbeltvaccination mod difteri og stivkrampe samt polio, ikke nærmere specificeret	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of first dose of poliomyelitis and tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Administration of second dose of poliomyelitis and tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Administration of third dose of poliomyelitis and tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Administration of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
dobbeltvaccinering mod difteri og stivkrampe samt polio i førskolealderen	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of first dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of second dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of third dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of first dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Administration of third dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Administration of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of booster dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of booster dose of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Administration of diphtheria, pertussis, and tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of first dose of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of second dose of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of fourth dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	3
Administration of first dose of diphtheria and Haemophilus influenzae type b and pertussis and poliomyelitis and tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	3
Administration of second booster of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Second low dose diphtheria, tetanus and inactivated polio vaccination	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Diphtheria/tetanus/pertussis/inactivated poliomyelitis vaccine 0.5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
stivkrampevaccination, ikke nærmere specificeret	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of final dose of vaccine product containing only Clostridium tetani antigen (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of booster dose of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of third dose of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of first dose of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of second dose of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Diphtheria + acellular pertussis adsorbed + inactivated polio + tetanus toxoids vaccine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	2
Allergy to diphtheria and tetanus vaccine	Causative agent	False	tetanusvaccine	Inferred relationship	Some	1
Allergy to tetanus vaccine	Causative agent	False	tetanusvaccine	Inferred relationship	Some	1
Allergy to diphtheria and pertussis and tetanus vaccine	Causative agent	False	tetanusvaccine	Inferred relationship	Some	1
Allergy to diphtheria and tetanus vaccine	Causative agent	False	tetanusvaccine	Inferred relationship	Some	4
Tetanus toxoid adsorbed	Is a	False	tetanusvaccine	Inferred relationship	Some
Administration of tetanus, diphtheria, and acellular pertussis vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of diphtheria and tetanus vaccine, less than 7 years of age	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for conventional release solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some
Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus and inactivated whole Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	2
Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	3
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	3
Administration of first dose of diphtheria and Haemophilus influenzae type b and hepatitis B and pertussis and tetanus vaccine	Direct substance	False	tetanusvaccine	Inferred relationship	Some	1
Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	5
Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for conventional release solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	2
Vaccination for diphtheria, pertussis, tetanus, poliomyelitis, Hepatitis B virus and Haemophilus influenzae type b	Direct substance	False	tetanusvaccine	Inferred relationship	Some	4
Haemophilus influenzae type b-vaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + kighostevaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt sprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	2
Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure)	Direct substance	False	tetanusvaccine	Inferred relationship	Some	3
adsorberet difteri- + tetanusvaccine injektionsvæske, suspension i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	1
difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighoste-vaccine 25 µg + rekombinant hepatitis B-virusoverfladeantigen 10 µg + inaktiveret poliovaccine injektionsvæske, opløsning 0,5 ml i fyldt injektionssprøjte	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	3
difteritoxoid 30 IE/tetanustoxoid 40 IE/acellulær kighostetoxoid 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	3
adsorberet tetanustoxoid 20 enheder/ml 0,5 ml injektionsvæske, opløsning, ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	1
rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighostevaccine 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	tetanusvaccine	Inferred relationship	Some	4

Start Page 2 of 2

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2467827018	Tetanus vaccine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2473955018	Tetanus vaccine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2770133017	Tetanus toxoid	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3267751000005114	tetanusvaccine	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)